At our institute, we challenge the limitations of traditional medicine in the face of neurological deterioration and autoimmune disorders. By integrating the latest regenerative medicine techniques, we modulate the immune system's response to stop the body from attacking itself, while simultaneously stimulating the neural environment and sensory receptors to repair damaged cells and restore lost motor functions.

• Auto-Destruction Suppression: Slowing the progression of intractable autoimmune diseases (such as multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis) and protecting healthy tissues from immune attack.

• Drug Toxicity Reduction: Reducing chronic dependence on corticosteroids and chemical immunosuppressants by significantly lowering systemic inflammation levels.

• Exceptional Success Rates: Achieving clinically proven success rates of 30% in direct response to slow disease progression and reduce radicular inflammation in target tissues.

The institute employs a precise and well-developed protocol, overseen by a select group of physicians and researchers. This protocol includes:

• Advanced Neuroprotection and Regeneration: Injection of stem cells capable of secreting targeted neurotrophic factors to support damaged neurons.

• Cellular Crossover and Stimulation: Supporting cells and proteins are directed to cross the blood-brain barrier, slowing neuronal aging and damage, and stimulating the formation of new neural connections and motor and sensory pathways (neuroplasticity).

• Schedule: The protocol includes a customized and intensive treatment plan conducted over a full year (injection sessions every three months, concurrent with precise functional and motor stimulation programs).

• Restoration of Motor and Sensory Function: Stimulation of motor abilities, neuromuscular coordination, and restoration of sensory signals in cases of spinal cord injuries and neurodegeneration.

• Freezing Neurodegeneration: Reducing the rapid cognitive and motor decline associated with diseases such as Parkinson's and Alzheimer's, and preserving patient independence for as long as possible.

• Exceptional Success Rates: Achieving promising clinical success rates of up to 45% in stimulating motor and sensory functions and sustainably slowing neurodegeneration, thus providing patients with a better quality of life.

The Institute is a pioneer in developing innovative treatment solutions for neurological disorders, harnessing the latest technologies in regenerative medicine and cell therapy to make a real difference in the lives of individuals with autism. By integrating advanced clinical research with superior medical care, the Institute strives to improve the efficiency of nerve cells and enhance patients' cognitive and behavioral abilities.

The Institute employs a precise and well-developed timeline protocol under the supervision of a select group of physicians and researchers. This protocol includes:

• Advanced Cell Therapy: Utilizing stem cells and stimulating advanced cellular applications (such as microalveolar stromal cells/exosomes) capable of indirectly or directly targeting the central nervous system and brain tissue.

• Dual Activation Mechanism: Injecting targeted cells that work on two pathways; the first modulates the immune response and reduces chronic inflammation in the brain (neuroinflammation), while the second stimulates neuroplasticity and regenerates damaged neural connections to improve blood flow to affected areas.

• Restoration of Functional Capacity: Enhancing cognitive abilities, improving verbal and nonverbal communication skills, and gradually developing social interaction in the patient.

• Protection from Complications and Associated Disorders: Reducing stereotypical and repetitive behaviors, controlling episodes of anger and acute anxiety, and improving sleep quality and gastrointestinal function, which are often associated with the disorder.

• Exceptional Success Rates: Achieving advanced clinical response rates in behavior modification and social integration, and reducing dependence on traditional psychiatric and neurological medications.